Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
This share is distributed to the Department of Health (DOH).[1]
With limited exceptions,[2] this share must be spent on forward-looking approved uses described in Exhibit A of Wyoming’s MOUs,[3] which is a variation of the national settlement agreement’s Exhibit E, Schedule B (“Approved Uses”) that allows for a broader variety of law enforcement-related uses.[4]
Reimbursement uses of opioid settlement funds are explicitly prohibited.[5]
Department of Health decides. The Wyoming Department of Health (DOH) ultimately decides how to spend this share on Exhibit A uses, including as grants for approved uses.[6] In past years, funds have primarily been allocated to projects within DOH’s Behavioral Health Division and Public Health Division.[7]
No, supplantation is not prohibited. Like most states, Wyoming does not explicitly prohibit supplantation uses of its opioid settlement funds. This means that the state share may be spent in ways that replace (or “supplant”) — rather than supplement — existing resources.
Yes (public reporting required). View the state share’s annual report here. The “State” is required to publish an online report each year on its expenditures, including funds expended by DOH and any grants awarded.[8]
Visit OpioidSettlementTracker.com’s Expenditure Report Tracker for an updated collection of states’ and localities’ available expenditure reports.
Not applicable.
OneWyo Opioid Settlement Memorandum of Agreement (MOA I) Sec. II.A) and OneWyo II Opioid Settlement Memorandum of Agreement (MOA II) Sec. II.A ((“35% allocated to the State (Statewide Share)”); MOA I Sec. IV.A and MOA II Sec. IV.A (“Unless newly-enacted legislation or the terms of a Settlement that becomes an order of a court provides otherwise, the Statewide Share will be distributed to the Wyoming Department of Health through the Wyoming Attorney General acting as trustee, agent, or attorney-in-fact to hold and distribute such amount, under Wyo. Stat. Ann. § 9-1-639(a), exclusively for abating the opioid crisis throughout Wyoming”). Note that MOA II — which applies to the settlements with Allergan, Teva, CVS, Walgreens, and Walmart — applies a different allocation to the monies associated with the Teva Settlement specifically (25% instead of 35% to the state share). MOA I applies only to the Distributor and Janssen settlements, and the Purdue Bankruptcy. See MOA I Sec. I.J and Amendment One to the OneWyo Opioid Settlement Memorandum of Agreement (Amendment to MOA I) Sec. 4.F. ↑
MOA I Sec. I.E and MOA II Sec. I.E (defining “Opioid Funds” to exclude attorneys’ fees or “any funds made available in a National Settlement Agreement or any Bankruptcy Resolution for the reimbursement of the United States Government”). ↑
MOA I Sec. I.A and MOA II Sec. I.A (defining “Approved Use(s) to mean “any opioid or co-occurring substance use disorder related strategies, projects, or programs that fall within, or are reasonably related or otherwise consistent with, the list of uses set out in Exhibit A”). MOA I Sec. III.A and MOA II Sec. III.A (“Regardless of allocation, all Opioid Funds must be used in a manner consistent with the Approved Uses definition”). ↑
See, e.g., Exhibit A Sec. J.1 (providing that “[p]articipating Local Governments may also use their share of funds for law enforcement expenditures relating to the opioid epidemic”). ↑
MOA I Sec. III.A and MOA II Sec. III.A (“No Opioid Funds will be used as restitution for past expenditures. Rather, Opioid Funds must be used in a present and forward-looking manner to actively abate and alleviate the impacts of the opioid crisis and co-occuring substance abuse in Wyoming”). ↑
MOA Sec. III.B and MOA II Sec. III.B (“The Statewide Share must be used only for (1) Approved Uses within the State of Wyoming or (2) grants for Approved Uses within the State of Wyoming. The State of Wyoming, Department of Health will serve as the lead agency responsible for distributing and using the Statewide Share in a manner that in its judgment will best address the opioid crisis within the State”). See also Wyoming Statewide Share of Opioid Funds Report. Wyoming Department of Health (DOH). January 2024. Accessed September 1, 2024 (describing itself as the “lead agency for the Statewide Share of Opioid Funds”). ↑
See, e.g., Wyoming Statewide Share of Opioid Funds Report. Wyoming Department of Health (DOH). January 2024. Accessed September 1, 2024. ↑
MOA I Sec. VI.F and MOA II Sec. VI.F (“By January 31 of each calendar year, the State shall publish online a report detailing for the preceding calendar year: (1) the amount of the Statewide Share received; (2) the amount of the Statewide Share expended by the Department of Health — broken down by funded strategy, project, or program; and (3) the amount of any grants awarded — listing the recipients, amounts awarded, amounts disbursed, disbursement terms, and programs, strategies, and projects funded”). ↑
Here are the entities that ultimately decide how each of Wyoming’s opioid settlement shares are spent:
65% local share: local officials for cities and counties
35% state share: Wyoming Department of Health
This share is distributed directly to participating counties and cities according to Exhibit B of Wyoming’s MOUs.[1] Non-participating localities’ amounts are reallocated to participating localities,[2] who may each opt to redirect their shares to the state share.[3]
Up to 15% of this share can be spent on attorneys’ fees.[4] Otherwise, and with limited exceptions,[5] this share must be spent on forward-looking approved uses described in Exhibit A of Wyoming’s MOUs,[6] which is a variation of the national settlement agreement’s Exhibit E, Schedule B (“Approved Uses”) that allows for a broader variety of law enforcement-related uses.[7]
Reimbursement uses of opioid settlement funds are explicitly prohibited.[8]
Local governments decide autonomously (but must certify proper uses). Decisionmakers for the counties and municipalities will ultimately decide for themselves how to spend their monies on Exhibit A uses,[9] but each is required to certify to the Wyoming Attorney General that it will spend its share on approved uses prior to receiving disbursement of funds,[10] in addition to annually certify spending on approved uses and reporting expenditures for the preceding year to the AG.[11]
Counties are additionally required to consult and “regularly” receive input from their cities and towns.[12] Local governments are encouraged to collaborate with each other on abatement efforts and are explicitly empowered to grant their shares to organizations.[13]
No, supplantation is not prohibited. Like most states, Wyoming does not explicitly prohibit supplantation uses of its opioid settlement funds. This means that the local share may be spent in ways that replace (or “supplant”) — rather than supplement — existing resources.
Up to each locality (no public reporting required, only intrastate). Opioid settlement expenditures are not officially published in a centralized location for this share. Participating local governments must annually report their expenditures only to the Attorney General.[14]
Visit OpioidSettlementTracker.com’s Expenditure Report Tracker for an updated collection of states’ and localities’ available expenditure reports.
Media coverage has described how Wyoming's local governments have been slow to spend down their shares. In 2023, local governments reportedly received more than $7.5 million in opioid settlement funds; however, and “according to reports sent to the Wyoming Attorney General’s Office[,] … leaders only spent or allocated about 5.6% of that.”[15]
OneWyo Opioid Settlement Memorandum of Agreement (MOA I) Sec. II.A) and OneWyo II Opioid Settlement Memorandum of Agreement (MOA II) Sec. II.A (“65% allocated to the Participating Local Governments (Localized Share)”); MOA I Sec. I.F and MOU II Sec. I.F (defining “Participating Local Governments” to mean “all counties, cities, and towns within the geographic boundaries of the State of Wyoming” that have signed on to the respective MOU); and MOA I Sec. IV.B and MOA II Sec. IV.B (local share “will be distributed directly to each Participating Local Government”). Exhibit B is an attachment to both MOU I and MOU II that describes local governments’ allocation percentages. Note that MOA II — which applies to the settlements with Allergan, Teva, CVS, Walgreens, and Walmart — applies a different allocation to the monies associated with the Teva Settlement specifically (75% instead of 65% to the Local Share). MOA I applies only to the Distributor and Janssen settlements, and the Purdue Bankruptcy. See MOA I Sec. I.J and Amendment One to the OneWyo Opioid Settlement Memorandum of Agreement (Amendment to MOA I) Sec. 4.F. ↑
MOA I Sec. II.C and MOA II Sec. II.C (providing that a non-Participating Government’s allocation is reallocated to the Local Share and distributed according to “the remaining proportions set for in Exhibit B”). ↑
MOA I Sec. II.D and MOA II Sec. II.D (“Any Participating Local Government allocated a share in Exhibit B may elect to direct its share of current or future annual distributions of Localized Share Funds to the Statewide Share”). ↑
MOA I Sec. V.C , Amendment to MOA I Sec. 4.G, and MOA II Sec. V.C (limiting payment to attorneys’ fees to no more than 15% of monies received by local governments). ↑
MOA I Sec. I.E and MOA II Sec. I.E (defining “Opioid Funds” to exclude attorneys’ fees or “any funds made available in a National Settlement Agreement or any Bankruptcy Resolution for the reimbursement of the United States Government”). ↑
MOA I Sec. I.A and MOA II Sec. I.A (defining “Approved Use(s) to mean “any opioid or co-occurring substance use disorder related strategies, projects, or programs that fall within, or are reasonably related or otherwise consistent with, the list of uses set out in Exhibit A”). MOA I Sec. III.A and MOA II Sec. III.A (“Regardless of allocation, all Opioid Funds must be used in a manner consistent with the Approved Uses definition”). ↑
See, e.g., Exhibit A Sec. J.1 (providing that “[p]articipating Local Governments may also use their share of funds for law enforcement expenditures relating to the opioid epidemic”). ↑
MOA I Sec. III.A and MOA II Sec. III.A (“No Opioid Funds will be used as restitution for past expenditures. Rather, Opioid Funds must be used in a present and forward-looking manner to actively abate and alleviate the impacts of the opioid crisis and co-occuring substance abuse in Wyoming”). ↑
MOA I Sec. III.C and MOA II Sec. III.C (“The Localized Share must be used only for (1) Approved Uses by Participating Local Governments or (2) grants for Approved Uses”). See, e.g., Fremont County (describing creation of workgroup to determine county allocations). ↑
MOA I Sec. VI.B and MOA II Sec. VI.B (required certification to the AG that a locality will spend its share on approved uses prior to disbursement). ↑
MOA I Sec. VI.C and MOA II Sec. VI.C (“By January 31 of each calendar year, each Participating Local Government shall certify to the Attorney General that all Opioid Funds expended during the preceding calendar year were used in accordance with this MOA on projects, programs, and strategies that constitute Approved Uses. In submitting this certification, each Participating Local Government shall include a report detailing for the preceding calendar year: (1) the amount of the Localized Share received by the Participating Local Government; (2) the amount of Localized Share expended by the Participating Local Government—broken down by funded project, program, or strategy; and (3) the amount of any allocations awarded by the Participating Local Government—listing the recipients, amounts awarded, amounts disbursed, disbursement terms, and the projects, programs, or strategies funded”) ↑
MOA I Sec. III.D and MOA II Sec. III.D (“Each Participating County shall regularly consult with and receive input from its constituent cities and towns regarding effective distribution and use of the Localized Share Funds. Each Participating County shall make reasonable and good faith efforts to not only secure the collaboration of each of its constituent cities and towns, but also to use the Opioid Funds in a manner that benefits the residents of each constituent city and town, regardless of population”). ↑
MOA I Sec. III.E and MOA II Sec. III.E (“Notwithstanding any term of this MOA, Participating Local Governments may collaborate with local governments both within and beyond their borders for the purpose of more effectively using Opioids Funds to abate the opioid crisis”). MOA I Sec. III.C and MOA II Sec. III.C (authorizing grants for approved uses). ↑
MOA I Sec. VI.C and MOA II Sec. VI.C. ↑
Madelyn Beck. More than 90% of Wyoming’s local opioid settlement money goes unspent while overdose deaths climb. WyoFile. April 22, 2024. Accessed September 1, 2024. ↑
This Community Guide will describe how Wyoming is spending its opioid settlements and whether Wyoming is working to ensure community access to opioid settlement funds. Last revised September 1, 2024.
Ultimate Decisionmaker
Local officials for cities and counties
Decision-making Process
Localities decide autonomously but must certify proper uses to the .
Counties are also required to regularly seek input from their cities and towns on uses of funds.
The Wyoming Department of Health decides how this share is distributed and used.
Supplantation
Not prohibited
Not prohibited
Grant Funding
Up to each locality (availability and processes will vary)
No
Public Input
Up to each locality (not required)
No opportunities available (not required)
Advisory Body
Up to each locality (not required)
No (not required)
Expenditures
No public reporting required (only intrastate)
Public reporting required. View annual reports on the Department of Health’s page (e.g., ).
Updates
To find updates on the local share, a good starting point is to check the websites for your county commission, city council, or local health department.
For updates on the state share, visit the Wyoming Department of Health’s page.
Statewide Share of Opioid Funds Annual Report (January 31, 2024)
Fatal Overdoses in Wyoming (2020)
No. Wyoming has not established an advisory body to inform opioid settlement spending.
Not applicable.
Not applicable.
No (up to each locality). Local governments in Wyoming are not required to establish opioid settlement advisory bodies. However, localities may choose to establish advisory councils that include members with lived and/or living experience to help ensure that settlement spending reflects community priorities.
Not applicable.
65% local share: Up to each locality (not required). Local governments are not required to seek public input on uses of their shares. However, each may choose to seek such input. Watch for opportunities to weigh in on city and county spending decisions, such as city council meetings and town halls.
35% state share: No opportunities available (not required). The state has not established recurring opportunities for the public to provide input on uses of its share.[1]
It depends. As of September 1, 2024, the state has not yet established any grant opportunities for the 35% state share. Local governments may create grant programs to distribute their share of funds. The existence, parameters, and processes for local settlement grant programs will vary by locality, so stay alert for new opportunities. Visit the Opioid Settlement Community Grants Portal (OpioidSettlementTracker.com and Legal Action Center) for the most up-to-date information on settlement grant opportunities for community organizations.
For updates on the state share, visit the Wyoming Department of Health’s Opioid Settlement Funds page.
To find updates on the local share, a good starting point is to check the websites for your county commission, city council, or local health department.
Not applicable.
If you see this change, email tips@opioidsettlementtracker.com. ↑
$84.45 million[1]
[1] Total is rounded. See The Official Opioid Settlement Tracker Tally. Accessed September 1, 2024.
65% to local governments and 35% to the state